FDA
approval
· 2025-03-07
FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)
Summary
The FDA approved a supplemental application for GLATOPA, Sandoz's generic glatiramer acetate. This product is used for treating multiple sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLATOPA (GLATIRAMER ACETATE)